VANTAGE Trademark

Trademark Overview

On Wednesday, January 4, 2023, a trademark application was filed for VANTAGE with the United States Patent and Trademark Office. The USPTO has given the VANTAGE trademark a serial number of 97741872. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 28, 2024. This trademark is owned by KolosisBio, LLC. The VANTAGE trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft bone and tissue; Human allograft tissue
vantage

General Information

Serial Number97741872
Word MarkVANTAGE
Filing DateWednesday, January 4, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHuman allograft bone and tissue; Human allograft tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKolosisBio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSalt Lake City, UT 84124

Trademark Events

Event DateEvent Description
Tuesday, June 13, 2023ASSIGNED TO EXAMINER
Saturday, January 7, 2023NEW APPLICATION ENTERED
Sunday, January 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 13, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, June 13, 2023SUSPENSION LETTER WRITTEN
Tuesday, June 13, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 16, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, February 9, 2024NON-FINAL ACTION WRITTEN
Friday, February 9, 2024NON-FINAL ACTION E-MAILED
Friday, February 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 28, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, May 28, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords

vantage tissue allograft human bone